Virafin

Ramdev_Reuters

Patanjali Anti-Allopathy Ad, a Window Into All That’s Wrong With Our Healthcare

Vasudevan Mukunth 11/07/2022

On July 10, Baba Ramdev's companies ran half-page ads...

FILE PHOTO: A health official draws a dose of the AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India, at Infectious Diseases Hospital in Colombo

COVID-19: India Has a Habit of Bad Clinical Trials

Ronak Borana 19/06/2021

Bharat Biotech's small paediatric trial is one of many...

vg somani

Dr Reddy’s Revealed More About 2-DG, and Its Approval Is More Confusing Now

Ronak Borana 04/06/2021

Several experts to whom The Wire Science reached out...

49531042877_e86ca079f2_c (1)

In the Time of COVID-19, ‘What’s the Harm’ Prescriptions Are Not Harmless

Vivekanand Jha 27/05/2021

We know that for the outcomes that matter to...

analuisa-gamboa-WsTP_d3VEgk-unsplash

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

Ronak Borana 25/05/2021

Many COVID-19-related clinical trials have several methodological flaws, and...

kvr_vkp_bb

COVID in India: 35 Questions for K. VijayRaghavan, V.K. Paul and Balram Bhargava

Karan Thapar 30/04/2021

The government's top scientists have been giving interviews and...

Spread of the coronavirus disease (COVID-19), in New Delhi

DCGI Approves Virafin for Moderate COVID. Where’s the Evidence It Works?

Ronak Borana 24/04/2021

Virafin's phase 2 trial has several methodological and reporting...